BMS has reported topline outcomes from the ARISE trial of Cobenfy as an adjunctive treatment to atypical antipsychotics for ...

The impact of long-acting injectables (LAIs) for HIV was discussed at the 35th ESCMID Global conference in Vienna, Austria.

Gilead Sciences has reported positive topline data from the Phase III ASCENT-04/KEYNOTE-D19 trial of Trodelvy and MSD’s ...

Daiichi and AstraZeneca's Enhertu with pertuzumab has shown PFS improvement in the Phase III DESTINY-Breast09 trial.

Enlivex has completed the enrollment of all subjects in the Phase II stage of the Phase I/II trial of Allocetra for severe ...

Alector has completed subject enrolment in the Phase II trial of AL101/GSK4527226 in individuals with early Alzheimer's ...

A Phase I/II trial by Japan’s Kyoto University Hospital and CiRA team has demonstrated outcomes with allogeneic iPS ...

Advarra has integrated its Center for IRB Intelligence (CIRBI) with the Study Collaboration for visibility into trial site ...

The interplay between sex and serious bacterial infections, including bacteremia and sepsis, is complex and more research is needed.

Lilly plans to submit orforglipron for approval in weight management by the end of 2025, with a T2D application to follow in ...